• Citer

Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.

par Major, P;Lortholary, Alain;Hon, J.;Abdi, E;Mills, Gordon B;Menssen, H D;Yunus, F;Bell, Richard H;Body, Jean-Jacques ;Quebe-Fehling, E;Seaman, J
Référence Journal of clinical oncology, 19, 2, page (558-567)
Publication Publié, 2001-01

Article révisé par les pairs

• Détails
• Contenu

Résumé :

Two identical, concurrent, parallel, multicenter, randomized, double-blind, double-dummy trials were conducted to compare the efficacy and safety of zoledronic acid and pamidronate for treating hypercalcemia of malignancy (HCM).